Insider trade

Director received an award of 560.9 BMY derivative securities

Traded Sep 30, 2026 · Filed Oct 3, 2026

Bristol Myers SquibbBMY

560.9
Derivative units · @ $62.40

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 30, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 3, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001418949-26-000010
Filed / recorded

Oct 3, 2026, 12:23 AM UTC

Added to OQRO

Oct 3, 2026, 11:40 AM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BRISTOL MYERS SQUIBB CO

Issuer CIK

14272

Ticker

BMY

Reporting person

Michael R. Mcmullen

Relationship

Director

Security

Deferred Share Units

Table

Derivative (Table II)

Transaction date

Sep 30, 2026

Transaction code

A

Shares / units

560.897

Price per share

$62.40

Acquired / disposed

Acquired (A)

Shares owned after

17,050.601

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.